Goldman Sachs Group, Inc. (The) set a €97.00 ($114.12) target price on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research report report published on Tuesday morning. The firm currently has a buy rating on the stock.

Other equities research analysts also recently issued reports about the stock. UBS AG set a €68.00 ($80.00) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a sell rating in a research note on Wednesday, May 3rd. Citigroup Inc. set a €92.00 ($108.24) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Friday, June 9th. J P Morgan Chase & Co set a €106.40 ($125.18) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Tuesday, June 13th. Berenberg Bank set a €95.00 ($111.76) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Friday, June 30th. Finally, Commerzbank Ag set a €88.00 ($103.53) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a report on Monday. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and ten have assigned a buy rating to the stock. The stock has an average rating of Hold and a consensus target price of €87.44 ($102.87).

Fresenius Medical Care AG & Co. KGaA (ETR FME) traded down 0.297% during trading on Tuesday, hitting €77.928. 1,522 shares of the stock traded hands. The firm has a market cap of €23.91 billion and a PE ratio of 20.095. The firm has a 50-day moving average price of €83.68 and a 200 day moving average price of €81.11. Fresenius Medical Care AG & Co. KGaA has a 12 month low of €70.82 and a 12 month high of €89.07.

ILLEGAL ACTIVITY NOTICE: “Fresenius Medical Care AG & Co. KGaA (FME) Given a €97.00 Price Target by Goldman Sachs Group, Inc. (The) Analysts” was originally published by Daily Political and is owned by of Daily Political. If you are accessing this report on another website, it was illegally copied and republished in violation of United States & international copyright & trademark legislation. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/08/09/fresenius-medical-care-ag-97-00-price-target-by-goldman-sachs-group-inc-the-analysts.html.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.